Pierre De Beaudrap

Summary

Country: France

Publications

  1. doi request reprint Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215)
    Pierre De Beaudrap
    Institut de recherche pour le developpement IRD, Université Montpellier1, Montpellier, France
    AIDS Res Hum Retroviruses 26:1221-7. 2010
  2. doi request reprint Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count
    Pierre De Beaudrap
    UMI 233 Institut de Recherche pour le Développement, Universite Montpellier I, Universite Cheikh Anta Diop, Universite de Yaounde I
    Pediatr Infect Dis J 32:354-60. 2013
  3. pmc Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment
    Pierre De Beaudrap
    Epicentre, Paris, France
    Malar J 12:139. 2013
  4. pmc Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort
    Pierre De Beaudrap
    Institut de recherche pour le developpement IRD, Universite Montpellier 1, UMR 145, Montpellier, F 34000, France
    BMC Infect Dis 10:179. 2010
  5. ncbi request reprint Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal
    Pierre De Beaudrap
    Hospices Civils de Lyon, Service de Biostatistique, Lyon, F 69003, France
    Am J Trop Med Hyg 80:1047-53. 2009
  6. doi request reprint CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Côte d'Ivoire
    Pierre De Beaudrap
    UMR 145, Institut de Recherche pour le Developpement, Montpellier, France
    J Acquir Immune Defic Syndr 49:70-6. 2008
  7. doi request reprint Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients
    Pierre De Beaudrap
    Hospices Civils de Lyon, Service de Biostatistique, Lyon, F 69424, France
    AIDS Res Hum Retroviruses 24:753-60. 2008
  8. doi request reprint Change over time of mortality predictors after HAART initiation in a Senegalese cohort
    Pierre De Beaudrap
    Hospices Civils de Lyon, Service de Biostatistique, Lyon, F 69424, France
    Eur J Epidemiol 23:227-34. 2008
  9. doi request reprint Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort
    Pierre De Beaudrap
    UMI 233, Institut de recherche pour le developpement IRD, Universite de Montpellier 1, Montpellier, France Laboratoire de Bactériologie Virologie, Hopital Le Dantec, Dakar, Sénégal Multisectorial AIDS Program, Dakar, Senegal Centre Régional de Recherche et Formation sur le VIH SIDA, Université Cheikh Anta Diop UCAD, UMI 233, Dakar, Sénégal Centre de traitement ambulatoire, CHU de Fann, Dakar, Senegal
    J Acquir Immune Defic Syndr 62:381-7. 2013
  10. pmc Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal
    Jean Francois Etard
    Institut de Recherche pour le Développement Université Montpellier 1 UMR 145, Montpellier, France
    Open AIDS J 3:63-70. 2009

Detail Information

Publications10

  1. doi request reprint Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215)
    Pierre De Beaudrap
    Institut de recherche pour le developpement IRD, Université Montpellier1, Montpellier, France
    AIDS Res Hum Retroviruses 26:1221-7. 2010
    ..A significant though moderate decline in the renal function was observed in one-third of the patients receiving TDF compared to patients not receiving TDF. Moreover, this impairment was persistent after the first year of treatment...
  2. doi request reprint Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count
    Pierre De Beaudrap
    UMI 233 Institut de Recherche pour le Développement, Universite Montpellier I, Universite Cheikh Anta Diop, Universite de Yaounde I
    Pediatr Infect Dis J 32:354-60. 2013
    ..The objective of this study was to document the incidence of AIDS-defining events and non-AIDS-defining diseases in African children receiving HAART...
  3. pmc Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment
    Pierre De Beaudrap
    Epicentre, Paris, France
    Malar J 12:139. 2013
    ....
  4. pmc Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort
    Pierre De Beaudrap
    Institut de recherche pour le developpement IRD, Universite Montpellier 1, UMR 145, Montpellier, F 34000, France
    BMC Infect Dis 10:179. 2010
    ..This study describes the incidence of AIDS-defining illnesses (ADI) after HAART initiation and analyzes their risk factors in a low-resource setting. A focus was put on CD4 cell counts and viral load measurements...
  5. ncbi request reprint Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal
    Pierre De Beaudrap
    Hospices Civils de Lyon, Service de Biostatistique, Lyon, F 69003, France
    Am J Trop Med Hyg 80:1047-53. 2009
    ....
  6. doi request reprint CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Côte d'Ivoire
    Pierre De Beaudrap
    UMR 145, Institut de Recherche pour le Developpement, Montpellier, France
    J Acquir Immune Defic Syndr 49:70-6. 2008
    ..To analyze the determinants of CD4 change in children during 3 periods: before highly active antiretroviral therapy (HAART), during the first year after HAART initiation, and past 1 year after HAART initiation...
  7. doi request reprint Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients
    Pierre De Beaudrap
    Hospices Civils de Lyon, Service de Biostatistique, Lyon, F 69424, France
    AIDS Res Hum Retroviruses 24:753-60. 2008
    ..Adverse effects were different between NVP and EFV, but long-term tolerance was good for both. This analysis provided further information on long-term tolerance and efficacy of EFV and NVP in a resource-limited setting...
  8. doi request reprint Change over time of mortality predictors after HAART initiation in a Senegalese cohort
    Pierre De Beaudrap
    Hospices Civils de Lyon, Service de Biostatistique, Lyon, F 69424, France
    Eur J Epidemiol 23:227-34. 2008
    ..Initial studies have demonstrated the feasibility and efficacy of this initiative. Analyses showed a peak of mortality short after starting HAART warranting an investigation of early and late mortality predictors...
  9. doi request reprint Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort
    Pierre De Beaudrap
    UMI 233, Institut de recherche pour le developpement IRD, Universite de Montpellier 1, Montpellier, France Laboratoire de Bactériologie Virologie, Hopital Le Dantec, Dakar, Sénégal Multisectorial AIDS Program, Dakar, Senegal Centre Régional de Recherche et Formation sur le VIH SIDA, Université Cheikh Anta Diop UCAD, UMI 233, Dakar, Sénégal Centre de traitement ambulatoire, CHU de Fann, Dakar, Senegal
    J Acquir Immune Defic Syndr 62:381-7. 2013
    ..Although good outcomes over the first years of ART have been observed in sub-Saharan Africa, little is known about the long-term (>5 years) risks of virological failure and drug resistance and about second-line treatment response...
  10. pmc Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal
    Jean Francois Etard
    Institut de Recherche pour le Développement Université Montpellier 1 UMR 145, Montpellier, France
    Open AIDS J 3:63-70. 2009
    ..Estimate tuberculosis (TB) incidence among patients receiving HAART. Compare the dynamic of the CD4-cell count and viral load before notification of the TB with the dynamic among patients remaining free of TB...